Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4114 stock hub

TPEX/4114 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4114is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.6B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4114

In the news

Latest news · TPEX/4114

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E18.6

P25 14.4P50 18P75 31.9

ROE6.7

P25 -16.2P50 0.3P75 9.8

ROIC6

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4114 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

TWD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Enterprise value	TWD 16.5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004114004
Last refreshed	2026-05-10
Market cap	TWD 15.6B
Price	TWD 30.95
Price currency	TWD
Sector	Healthcare
Sic	2834
Symbol	tpex/4114
Website	https://www.synmosa.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.28%
EV Earnings	20.05x
EV/EBIT	21.91x
EV/EBITDA	15.15x
EV/FCF	105.54x
EV/Sales	2.66x
FCF yield	1%
P/B ratio	1.54x
P/E ratio	18.64x
P/S ratio	2.51x
PE Ratio10 Y	56.14x
PE Ratio3 Y	22.6x
PE Ratio5 Y	21.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.58%
EBITDA Margin	17.56%
FCF margin	2.52%
Gross margin	43.28%
Gross Profit	TWD 2.7B
Gross Profit Growth	11.57%
Gross Profit Growth Q	4.18%
Gross Profit Growth3 Y	13.61%
Gross Profit Growth5 Y	18.78%
Net Income	TWD 821.8M
Net Income Growth	20.03%
Net Income Growth Q	37.8%
Net Income Growth Quarters	4%
Net Income Growth Years	0%
Net Income Growth3 Y	0.94%
Net Income Growth5 Y	5.19%
Pretax Margin	12.92%
Profit Margin	13.28%
Profitable Years	7
ROA	3.7
Roa5y	2.94
ROCE	6.64
ROE	6.69
Roe5y	5.9
ROIC	5.95
Roic5y	4.65

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.5%
Cagr15y	9.15%
Cagr1y	7.47%
Cagr20y	13.33%
Cagr3y	-3.42%
Cagr5y	16.24%
Div CAGR10	23.89%
Div CAGR3	9.15%
Div CAGR5	23.62%
EPS Growth	12.16
EPS Growth Q	28.02
EPS Growth Quarters	2
EPS Growth Years	2
EPS Growth3 Y	-3.57
EPS Growth5 Y	1.99
FCF Growth	-72.42%
FCF Growth Q	-35.98%
FCF Growth3 Y	-32.2%
FCF Growth5 Y	9.32%
OCF Growth	-47.28%
OCF Growth Q	-25.01%
OCF Growth10 Y	33.09%
OCF Growth3 Y	-13.24%
OCF Growth5 Y	10.1%
Revenue Growth	11.53x
Revenue Growth Q	5.33x
Revenue Growth Quarters	9x
Revenue Growth Years	6x
Revenue Growth3 Y	12.16x
Revenue Growth5 Y	15.29x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.47
Assets	TWD 14B
Cash	TWD 2.9B
Current Assets	TWD 6.7B
Current Liabilities	TWD 2.3B
Debt	TWD 2.5B
Debt EBITDA	TWD 2.26
Debt Equity	TWD 0.25
Debt FCF	TWD 16.1
Equity	TWD 10.1B
Interest Coverage	12.55
Liabilities	TWD 3.9B
Long Term Assets	TWD 7.3B
Long Term Liabilities	TWD 1.6B
Net Cash	TWD 418.2M
Net Cash By Market Cap	TWD 2.69
Net Debt EBITDA	TWD -0.38
Net Debt Equity	TWD -0.04
Net Debt FCF	TWD -2.68
Tangible Book Value	TWD 8.3B
Tangible Book Value Per Share	TWD 16.57
WACC	3.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.95
Inventory Turnover	1.74
Net Working Capital	TWD 2.4B
Quick ratio	1.93
Working Capital	TWD 4.4B
Working Capital Turnover	TWD 1.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-7%
Dividend Growth	9.82%
Dividend Growth Years	5%
Dividend per share	TWD 0.85
Dividend Years	15
Dividend Yield	2.75%
Ex Div Date	2025-07-11
Last Dividend	TWD 0.6
Payout Frequency	Annual
Payout Ratio	33.17%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	171.26%
1Y total return	7.47%
200-day SMA	33.23
3Y total return	-9.91%
50-day SMA	31.29
50-day SMA vs 200-day SMA	50under200
5Y total return	112.19%
All Time High	42.2
All Time High Change	-26.66%
All Time High Date	2022-12-26
All Time Low	1.99
All Time Low Change	1,456.06%
All Time Low Date	2004-08-24
ATR	0.35
Beta	0
Beta1y	0.28
Beta2y	0.29
Ch YTD	-4.48
High	31.35
High52	39.8
High52 Date	2025-08-05
High52ch	-22.24%
Low	30.85
Low52	29.37
Low52 Date	2025-05-08
Low52ch	5.71%
Ma50ch	-1.08%
Price vs 200-day SMA	-6.85%
RSI	44.03
RSI Monthly	47.06
RSI Weekly	41.52
Sharpe ratio	0.46x
Sortino ratio	1.06
Total Return	-4.25%
Tr YTD	-4.48
Tr15y	272%
Tr1m	-0.48%
Tr1w	0.65%
Tr3m	-4.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 778.5M
Operating Income Growth	5.07
Operating Income Growth Q	-5.84
Operating Income Growth3 Y	19.11
Operating Income Growth5 Y	39.1
Operating margin	12.58

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	389,483,730%
Net Borrowing	-46,350,000
Shares Insiders	9.38%
Shares Institutions	6.89%
Shares Out	502,772,000
Shares Qo Q	-0.56%
Shares Yo Y	7%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 120.3M
Average Volume	974,917x
Bv Per Share	17.43
CAPEX	TWD -255.4M
Ch10y	137
Ch15y	218
Ch1m	-0.48
Ch1w	0.65
Ch1y	5.71
Ch20y	864.8
Ch3m	-4.77
Ch3y	-15.01
Ch5y	94.68
Ch6m	-6.21
Change	-0.32%
Change From Open	-0.16
Close	31.05
Days Gap	-0.16
Depreciation Amortization	308,397,000
Dollar Volume	29,318,037.5
Earnings Date	2026-08-28
EBIT	TWD 778.5M
EBITDA	TWD 1.1B
EPS	TWD 1.66
F Score	7
FCF	TWD 156.1M
FCF EV Yield	0.95x
FCF Per Share	TWD 0.31
Financing CF	964,201,000
Fiscal Year End	December
Founded	1,959
Goodwill	50,257,000
Graham Number	25.51565
Graham Upside	-17.56
Income Tax	TWD 181.2M
Investing CF	-663,535,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2025-07-11
Last Split Type	Forward
Lynch Fair Value	TWD 8.62
Lynch Upside	-72.16
Ma150	32.34
Ma150ch	-4.31%
Ma20	31.25
Ma20ch	-0.94%
Net CF	705,136,000
Next Earnings Date	2026-08-28
Open	31
P FCF Ratio	99.66
P OCF Ratio	37.81
Payment Date	2025-08-15
Position In Range	20
Ppne	5,424,707,000
Price Date	2026-05-08
Price EBITDA	TWD 14.32
Ptbv Ratio	1.87
Relative Volume	0.99x
Revenue	6,189,262,000x
SBC By Revenue	0.58x
Share Based Comp	35,873,000
Tax By Revenue	2.93x
Tax Rate	22.66%
Tr20y	1,120.57%
Tr6m	-6.21%
Volume	947,271
Z Score	3.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4114 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.85 annual per share

Payout ratio

+33.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+23.6%

5 consecutive years of growth

Total shareholder yield

-4.3%

Next ex-dividend date: 2025-07-11

Performance

TPEX/4114 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4114?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.9%

Share of float held by funds and institutions

Insider ownership

+9.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+7.0%

Negative means the company is buying back shares.

Technical

TPEX/4114 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.0

Neutral momentum band

Price vs 200-day MA

-6.8%

50/200-day relationship not available

Beta (5Y)

0.00

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4114

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4114 stock rating?

tpex/4114 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4114 analysis?

The full report lives at /stocks/tpex/4114/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4114?

The latest report frames tpex/4114 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4114 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.